Neuro-peptide treatment with Cerebrolysin improves the survival of neural stem cell grafts in an APP transgenic model of Alzheimer disease.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Neuro-peptide treatment with Cerebrolysin improves the survival of neural stem cell grafts in an APP transgenic model of Alzheimer disease.
- Published In:
- Stem cell research, 15(1), 54-67 (2015)
- Authors:
- Rockenstein, Edward, Desplats, Paula, Ubhi, Kiren, Mante, Michael, Florio, Jazmin, Adame, Anthony, Winter, Stefan, Brandstaetter, Hemma, Meier, Dieter, Masliah, Eliezer
- Database ID:
- RPEP-02779
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02779APA
Rockenstein, Edward; Desplats, Paula; Ubhi, Kiren; Mante, Michael; Florio, Jazmin; Adame, Anthony; Winter, Stefan; Brandstaetter, Hemma; Meier, Dieter; Masliah, Eliezer. (2015). Neuro-peptide treatment with Cerebrolysin improves the survival of neural stem cell grafts in an APP transgenic model of Alzheimer disease.. Stem cell research, 15(1), 54-67. https://doi.org/10.1016/j.scr.2015.04.008
MLA
Rockenstein, Edward, et al. "Neuro-peptide treatment with Cerebrolysin improves the survival of neural stem cell grafts in an APP transgenic model of Alzheimer disease.." Stem cell research, 2015. https://doi.org/10.1016/j.scr.2015.04.008
RethinkPeptides
RethinkPeptides Research Database. "Neuro-peptide treatment with Cerebrolysin improves the survi..." RPEP-02779. Retrieved from https://rethinkpeptides.com/research/rockenstein-2015-neuropeptide-treatment-with-cerebrolysin
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.